Low Dose Aspirin Alerts in High-Risk Pregnancies

Description

The goal of this study is to assess the effect of an electronic health record (EHR) clinical decision support tool, also known as a best practice alert (BPA), on healthcare provider recommendations for low dose aspirin use in a high-risk pregnant patient population. The investigators hypothesize that the implementation of the EHR BPA tool will increase the healthcare provider's recommendation for low dose aspirin compared to current standard care.

Conditions

Preeclampsia, Aspirin, Clinical Decision Support Systems, Economics, Behavioral

Study Overview

Study Details

Study overview

The goal of this study is to assess the effect of an electronic health record (EHR) clinical decision support tool, also known as a best practice alert (BPA), on healthcare provider recommendations for low dose aspirin use in a high-risk pregnant patient population. The investigators hypothesize that the implementation of the EHR BPA tool will increase the healthcare provider's recommendation for low dose aspirin compared to current standard care.

Best Practice Alert (BPA) for Low Dose Aspirin Recommendation in High-risk Pregnancies: a Randomized Controlled Trial

Low Dose Aspirin Alerts in High-Risk Pregnancies

Condition
Preeclampsia
Intervention / Treatment

-

Contacts and Locations

Danville

Geisinger Medical Center, Danville, Pennsylvania, United States, 17822

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Receiving prenatal care within Geisinger
  • * Initial prenatal visit prior to 28 weeks gestation
  • * Determined to be high risk for preeclampsia based on the modified United States Preventive Services Task Force and American College of Obstetrics and Gynecology criteria (at least 1 high risk factor)
  • * Not pregnant
  • * No prenatal visit prior to 28 weeks gestation
  • * Maternal-Fetal Medicine only visits
  • * Not meeting the modified USPSTF high-risk criteria
  • * Contraindication to aspirin, including allergy

Ages Eligible for Study

to

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

Geisinger Clinic,

A. Dhanya Mackeen, MD, MPH, PRINCIPAL_INVESTIGATOR, Geisinger Clinic

Study Record Dates

2025-06-19